Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Nov 1;90(21):9808–9812. doi: 10.1073/pnas.90.21.9808

Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.

T M Dawson 1, J P Steiner 1, V L Dawson 1, J L Dinerman 1, G R Uhl 1, S H Snyder 1
PMCID: PMC47661  PMID: 7694293

Abstract

Immunosuppressants FK506 and cyclosporin A inhibit neurotoxicity of N-methyl-D-aspartate in primary cortical cultures, while having no effect on quisqualate- and kainate-mediated neurotoxicity. Rapamycin completely reverses the neuroprotective effect of FK506. Both FK506 and cyclosporin A inhibit NMDA-elicited/nitric oxide-mediated increases in cGMP levels in cortical cultures. FK506 has no effect on sodium nitroprusside-induced increases in cGMP. In a stably transfected human kidney 293 cell line overexpressing the gene encoding nitric oxide synthase [L-arginine, NADPH:oxygen oxidoreductase (nitric oxide-forming), EC 1.14.13.39], FK506 inhibits the calcium ionophore A23187, stimulated increases in nitrite (a breakdown product of nitric oxide), and potentiates phorbol ester-mediated inhibition of nitrite formation. FK506-mediated inhibition of nitric oxide formation is completely reversed by rapamycin. Calcineurin dephosphorylates protein kinase C-mediated phosphorylation of nitric oxide synthase. FK506 prevents the calcineurin-mediated dephosphorylation of nitric oxide synthase and thereby diminishes the enzyme's catalytic activity. These data establish nitric oxide synthase as a calcineurin substrate. Nitric oxide synthase catalytic activity is regulated by the phosphorylation state of the enzyme. Enhanced phosphorylation of nitric oxide synthase diminishes catalytic activity, and dephosphorylation (through activation of calcineurin) enhances catalytic activity. The neuroprotective effect of FK506 and cyclosporin A presumably involves the inhibition of calcineurin, preventing the dephosphorylation of nitric oxide synthase and its subsequent activation.

Full text

PDF
9808

Images in this article

9810Fig. 1
on p.9810
9810Fig. 2
on p.9810
9811Fig. 3
on p.9811

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begley D. J., Squires L. K., Zloković B. V., Mitrović D. M., Hughes C. C., Revest P. A., Greenwood J. Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J Neurochem. 1990 Oct;55(4):1222–1230. doi: 10.1111/j.1471-4159.1990.tb03128.x. [DOI] [PubMed] [Google Scholar]
  2. Bredt D. S., Ferris C. D., Snyder S. H. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem. 1992 Jun 5;267(16):10976–10981. [PubMed] [Google Scholar]
  3. Bredt D. S., Hwang P. M., Glatt C. E., Lowenstein C., Reed R. R., Snyder S. H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991 Jun 27;351(6329):714–718. doi: 10.1038/351714a0. [DOI] [PubMed] [Google Scholar]
  4. Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A. 1989 Nov;86(22):9030–9033. doi: 10.1073/pnas.86.22.9030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chang J. Y., Sehgal S. N., Bansbach C. C. FK506 and rapamycin: novel pharmacological probes of the immune response. Trends Pharmacol Sci. 1991 Jun;12(6):218–223. doi: 10.1016/0165-6147(91)90555-7. [DOI] [PubMed] [Google Scholar]
  6. Choi D. W. Bench to bedside: the glutamate connection. Science. 1992 Oct 9;258(5080):241–243. doi: 10.1126/science.1357748. [DOI] [PubMed] [Google Scholar]
  7. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988 Oct;1(8):623–634. doi: 10.1016/0896-6273(88)90162-6. [DOI] [PubMed] [Google Scholar]
  8. Correa-Rotter R., Mariash C. N., Rosenberg M. E. Loading and transfer control for Northern hybridization. Biotechniques. 1992 Feb;12(2):154–158. [PubMed] [Google Scholar]
  9. Dawson T. M., Dawson V. L., Snyder S. H. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol. 1992 Sep;32(3):297–311. doi: 10.1002/ana.410320302. [DOI] [PubMed] [Google Scholar]
  10. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., Snyder S. H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci. 1993 Jun;13(6):2651–2661. doi: 10.1523/JNEUROSCI.13-06-02651.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6368–6371. doi: 10.1073/pnas.88.14.6368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fruman D. A., Klee C. B., Bierer B. E., Burakoff S. J. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3686–3690. doi: 10.1073/pnas.89.9.3686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Galat A., Lane W. S., Standaert R. F., Schreiber S. L. A rapamycin-selective 25-kDa immunophilin. Biochemistry. 1992 Mar 3;31(8):2427–2434. doi: 10.1021/bi00123a031. [DOI] [PubMed] [Google Scholar]
  14. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991 Feb;14(2):60–67. doi: 10.1016/0166-2236(91)90022-m. [DOI] [PubMed] [Google Scholar]
  15. Halpain S., Girault J. A., Greengard P. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature. 1990 Jan 25;343(6256):369–372. doi: 10.1038/343369a0. [DOI] [PubMed] [Google Scholar]
  16. Halpain S., Greengard P. Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2. Neuron. 1990 Sep;5(3):237–246. doi: 10.1016/0896-6273(90)90161-8. [DOI] [PubMed] [Google Scholar]
  17. Izumi Y., Benz A. M., Clifford D. B., Zorumski C. F. Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices. Neurosci Lett. 1992 Feb 3;135(2):227–230. doi: 10.1016/0304-3940(92)90442-a. [DOI] [PubMed] [Google Scholar]
  18. Jin Y. J., Albers M. W., Lane W. S., Bierer B. E., Schreiber S. L., Burakoff S. J. Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6677–6681. doi: 10.1073/pnas.88.15.6677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jin Y. J., Burakoff S. J., Bierer B. E. Molecular cloning of a 25-kDa high affinity rapamycin binding protein, FKBP25. J Biol Chem. 1992 Jun 5;267(16):10942–10945. [PubMed] [Google Scholar]
  20. Koh J. Y., Peters S., Choi D. W. Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. Science. 1986 Oct 3;234(4772):73–76. doi: 10.1126/science.2875522. [DOI] [PubMed] [Google Scholar]
  21. Liu J., Albers M. W., Wandless T. J., Luan S., Alberg D. G., Belshaw P. J., Cohen P., MacKintosh C., Klee C. B., Schreiber S. L. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry. 1992 Apr 28;31(16):3896–3901. doi: 10.1021/bi00131a002. [DOI] [PubMed] [Google Scholar]
  22. Liu J., Farmer J. D., Jr, Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991 Aug 23;66(4):807–815. doi: 10.1016/0092-8674(91)90124-h. [DOI] [PubMed] [Google Scholar]
  23. Lopez O. L., Martinez A. J., Torre-Cisneros J. Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506. Transplant Proc. 1991 Dec;23(6):3181–3182. [PubMed] [Google Scholar]
  24. Mayer M. L., Benveniste M., Patneau D. K., Vyklicky L., Jr Pharmacologic properties of NMDA receptors. Ann N Y Acad Sci. 1992 May 11;648:194–204. doi: 10.1111/j.1749-6632.1992.tb24538.x. [DOI] [PubMed] [Google Scholar]
  25. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci. 1990 Sep;11(9):379–387. doi: 10.1016/0165-6147(90)90184-a. [DOI] [PubMed] [Google Scholar]
  26. Miller R. J. Metabotropic excitatory amino acid receptors reveal their true colors. Trends Pharmacol Sci. 1991 Oct;12(10):365–367. doi: 10.1016/0165-6147(91)90604-q. [DOI] [PubMed] [Google Scholar]
  27. Moncada C., Lekieffre D., Arvin B., Meldrum B. Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions. Neuroreport. 1992 Jun;3(6):530–532. [PubMed] [Google Scholar]
  28. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  29. Nakane M., Mitchell J., Förstermann U., Murad F. Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1396–1402. doi: 10.1016/s0006-291x(05)81351-8. [DOI] [PubMed] [Google Scholar]
  30. Nowicki J. P., Duval D., Poignet H., Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol. 1991 Nov 12;204(3):339–340. doi: 10.1016/0014-2999(91)90862-k. [DOI] [PubMed] [Google Scholar]
  31. Puttfarcken P. S., Lyons W. E., Coyle J. T. Dissociation of nitric oxide generation and kainate-mediated neuronal degeneration in primary cultures of rat cerebellar granule cells. Neuropharmacology. 1992 Jun;31(6):565–575. doi: 10.1016/0028-3908(92)90189-v. [DOI] [PubMed] [Google Scholar]
  32. Schoepp D., Bockaert J., Sladeczek F. Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors. Trends Pharmacol Sci. 1990 Dec;11(12):508–515. doi: 10.1016/0165-6147(90)90052-a. [DOI] [PubMed] [Google Scholar]
  33. Scholz W. K., Palfrey H. C. Glutamate-stimulated protein phosphorylation in cultured hippocampal pyramidal neurons. J Neurosci. 1991 Aug;11(8):2422–2432. doi: 10.1523/JNEUROSCI.11-08-02422.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schreiber S. L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991 Jan 18;251(4991):283–287. doi: 10.1126/science.1702904. [DOI] [PubMed] [Google Scholar]
  35. Steiner J. P., Dawson T. M., Fotuhi M., Glatt C. E., Snowman A. M., Cohen N., Snyder S. H. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature. 1992 Aug 13;358(6387):584–587. doi: 10.1038/358584a0. [DOI] [PubMed] [Google Scholar]
  36. Sutherland J. C., Sutherland B. M., Emrick A., Monteleone D. C., Ribeiro E. A., Trunk J., Son M., Serwer P., Poddar S. K., Maniloff J. Quantitative electronic imaging of gel fluorescence with CCD cameras: applications in molecular biology. Biotechniques. 1991 Apr;10(4):492–497. [PubMed] [Google Scholar]
  37. Swanson S. K., Born T., Zydowsky L. D., Cho H., Chang H. Y., Walsh C. T., Rusnak F. Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3741–3745. doi: 10.1073/pnas.89.9.3741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tai P. K., Albers M. W., Chang H., Faber L. E., Schreiber S. L. Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science. 1992 May 29;256(5061):1315–1318. doi: 10.1126/science.1376003. [DOI] [PubMed] [Google Scholar]
  39. Thomson A. W. FK-506--how much potential? Immunol Today. 1989 Jan;10(1):6–9. doi: 10.1016/0167-5699(89)90057-1. [DOI] [PubMed] [Google Scholar]
  40. Wallis R. A., Panizzon K., Wasterlain C. G. Inhibition of nitric oxide synthase protects against hypoxic neuronal injury. Neuroreport. 1992 Jul;3(7):645–648. doi: 10.1097/00001756-199207000-00026. [DOI] [PubMed] [Google Scholar]
  41. Yem A. W., Tomasselli A. G., Heinrikson R. L., Zurcher-Neely H., Ruff V. A., Johnson R. A., Deibel M. R., Jr The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J Biol Chem. 1992 Feb 15;267(5):2868–2871. [PubMed] [Google Scholar]
  42. Zorumski C. F., Thio L. L. Properties of vertebrate glutamate receptors: calcium mobilization and desensitization. Prog Neurobiol. 1992 Sep;39(3):295–336. doi: 10.1016/0301-0082(92)90020-f. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES